B
BeatO
Digital care ecosystem for comprehensive diabetes management.
About BeatO
BeatO, operating under Health Arx Technologies Pvt. Ltd., is a digital health platform focused on providing comprehensive and affordable solutions for diabetes management. Founded in August 2015 by Gautam Chopra, Yash Sehgal, and Abhishek Kumar, the company is headquartered in New Delhi, India. The inspiration for BeatO stemmed from co-founder Yash Sehgal's personal struggle with diabetes and the realization that the existing healthcare system for chronic ailments was fractured. A chance meeting with his childhood friend, Gautam Chopra, led to the identification of a market gap for a one-stop diabetes solution. They were joined by Kunal Kinalekar, who was later elevated to co-founder and CTO. Gautam Chopra, the CEO, has a background in business strategy, with an MBA from the Indian School of Business (ISB), Hyderabad, and international experience at Lufthansa. Yash Sehgal, the COO, has an MBA from the Indian Institute of Management, Kozhikode, and brings experience in operations and supply chain. Kunal Kinalekar, the CTO, is an engineer with a decade of experience in leading technology for marketing analytics and digital transformation at Publicis Groupe. BeatO's business model is a direct-to-consumer (B2C) subscription service. The company makes money through the sale of its health monitoring devices, subscription plans for its care programs, and a marketplace for diabetes-friendly products. The core of its offering is a smartphone-connected glucometer that syncs with the BeatO mobile app, allowing for real-time blood glucose tracking. This product-led acquisition strategy, centered on affordable starter kits, has facilitated capital-efficient growth. The platform provides an end-to-end digital ecosystem that includes automated blood sugar logging, real-time alerts for out-of-range readings, and AI-driven personalized insights. Users can connect with a team of diabetes educators, nutritionists, and doctors for consultations and personalized advice. The app also features an AI-powered chatbot for instant query resolution and allows users to track other vitals like blood pressure and heart rate. Beyond monitoring and consultations, BeatO operates a marketplace offering a variety of diabetes-specific products, such as healthy snacks, specialty foods, and footwear. The company also facilitates lab tests and medicine refills. BeatO has raised a total of $50.8 million across 12 funding rounds from investors including Lightrock India, HealthQuad, Flipkart Ventures, Blume Ventures, and Leo Capital. The company has a significant user base, with over 400,000 paid members, and has seen strong adoption in smaller towns, with nearly 70% of its users coming from beyond Tier 1 cities.
Source: Dealroom company dataAt a glance
- Status
- Operational
- Founded
- 2015
- Headquarters
- India
- Employees
- 400
- Open positions
- 2
- Dealroom signal
- 67.0/100
- Industry
- Health
- Sub-industry
- Health Platform
- Sector
- Health Tech & Medtech, Personal Health, Diabetes, Hard Tech
- Business model
- Marketplace & ecommerce
- Client focus
- b2b, b2c
- Investment activity
- 1 company, latest Sep 2021
- Capital deployed
- —
- Preferred round
- ACQUISITION
Knowledge graph
More headlines
Funding history
Company financing events and reported valuations.
| Deal type | Date | Amount | Valuation | Investors | Source |
|---|---|---|---|---|---|
| SERIES B✓Equity / VC | Nov 2022 | $33M | $132M | Orios Venture Partners · Flipkart · Leo Capital · HealthQuad | ↗ |
| DEBT✓Debt | Sep 2022 | $2.3M | — | Alteria Capital | ↗ |
Financials
Revenue, earnings and other financial measures where available. Years marked “E” are estimates.
Growth signals
Latest recorded traffic for BeatO is 220K monthly website visits, up 57.1% over the last three months. BeatO's team declined 4.1% over the past year.
Similar companies
Company identity and context are open; selected comparison metrics preview what is available on the platform.
Investments and acquisitions
Recent portfolio relationships for companies that also act as investors or acquirers.
Investors
From Dealroom's funding and investor records, grouped by the round each investor first entered.
Seed2 investors entered at this stage
Orios Venture Partners
Leo Capital
Series A8 investors entered at this stage
Blume Ventures- LHLeo Capital Holdings
PharmEasy
Merisis Advisors
W Health Ventures
Flipkart
HealthQuad
Lightrock
Series B and later3 investors entered at this stage
Sage Hill Capital
Kotak Investment Advisors
Alteria Capital
Source: Dealroom Talent Intelligence.
Global footprint
team presence
Market sentiment
An AI-synthesised read of the highest-engagement posts about BeatO on X, ranked by likes and reposts, corporate channels excluded.
Reading the room on X — pulling top posts and synthesizing themes…
Source: X recent search ranked by engagement (likes + retweets) · Synthesis by Claude · Cached for 1 hour
See BeatO’s full profile on Dealroom
Request a free trial to see the complete deal history, financials, people graph and growth signals.
Takes under a minute. Already use Dealroom? Log in.








